Akèy › Sinukleinopati
Etid klinik pou Sinukleinopati ap rekrite nan Etazini
5 etid pou Sinukleinopati ap rekrite patisipan nan sit atravè Etazini.
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
Ap rekriteFaz 2
Laj 55 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT07589595Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
Ap rekriteFaz 1
Laj 40 a 75 · Tout sèks · Mizajou Aug 31, 2026 · NCT06683365Slow-SPEED: Slowing Parkinson's Early Through Exercise Dosage
Ap rekrite
Laj 50 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT06993142An Exploratory Study of the Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons With REM Sleep Behavior Disorder (RBD)
Ap rekriteFaz 2
Laj 50 a 80 · Tout sèks · Mizajou Aug 24, 2026 · NCT06996652Tenapanor in Synucleinopathy-Related Constipation
Ap rekriteFaz 2
Laj 50 a 89 · Tout sèks · Mizajou Feb 10, 2025 · NCT06460038Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.